Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a …

YM Bezabih, A Bezabih, M Dion… - JAC-Antimicrobial …, 2022 - academic.oup.com
Objectives The widespread intestinal carriage of ESBL-producing Escherichia coli (ESBL E.
coli) among both patients and healthy individuals is alarming. However, the global …

Topical antimicrobials for burn wound infections

T Dai, YY Huang, S K. Sharma… - Recent patents on …, 2010 - benthamdirect.com
Throughout most of history, serious burns occupying a large percentage of body surface
area were an almost certain death sentence because of subsequent infection. A number of …

Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis

H Bar-Yoseph, K Hussein, E Braun… - Journal of Antimicrobial …, 2016 - academic.oup.com
Background ESBL-producing Enterobacteriaceae and carbapenem-resistant
Enterobacteriaceae (CRE) are rapidly spreading worldwide. Their natural reservoir is …

ICU acquisition rate, risk factors, and clinical significance of digestive tract colonization with extended-Spectrum Beta-lactamase–producing Enterobacteriaceae: a …

M Detsis, S Karanika, E Mylonakis - Critical care medicine, 2017 - journals.lww.com
Objective: To evaluate the acquisition rate, identify risk factors, and estimate the risk for
subsequent infection, associated with the colonization of the digestive tract with extended …

Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients–Review of the literature from a clinical …

LM Biehl, M Schmidt-Hieber, B Liss… - Critical reviews in …, 2016 - Taylor & Francis
Background: The prevalence of extended-spectrum β-lactamase producing
Enterobacteriaceae (ESBL-E) is increasing worldwide. ESBL-E are known to colonize …

Fecal carriage of extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals

AA Kader, A Kumar, KA Kamath - Infection Control & Hospital …, 2007 - cambridge.org
Fecal carriage of extended-spectrum β-lactamase (ESBL)-producing organisms was
assessed in 272 inpatients, 162 outpatients, and 426 asymptomatic healthy individuals. Of …

Acquisition of MDR-GNB in hospital settings: a systematic review and meta-analysis focusing on ESBL-E

J Vink, J Edgeworth, SL Bailey - Journal of Hospital Infection, 2020 - Elsevier
Introduction Extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) and
other multi-drug-resistant Gram-negative bacteria (MDR-GNB) have disseminated globally …

Escherichia coli Isolated from Urinary Tract Infections of Lebanese Patients between 2000 and 2009: Epidemiology and Profiles of Resistance

Z Daoud, C Afif - Chemotherapy Research and Practice, 2011 - Wiley Online Library
The purpose of this study was to investigate the bacterial etiology of urinary tract infections in
one of the busiest hospitals of Lebanon and to examine the epidemiologic and microbiologic …

[HTML][HTML] Escherichia coli Isolated from Urinary Tract Infections of Lebanese Patients between 2005 and 2012: Epidemiology and Profiles of Resistance

Z Daoud, E Salem Sokhn, K Masri, K Cheaito… - Frontiers in …, 2015 - frontiersin.org
The early treatment of urinary tract infections (UTIs) is directly related to decrease in
morbidity, which makes the empirical treatment of great importance. Recently, beta …

Antibacterial Activity of the Extracts Obtained from Rosmarinus officinalis, Origanum majorana, and Trigonella foenum-graecum on Highly DrugResistant Gram …

R Abdel-Massih, E Abdou, E Baydoun… - Journal of …, 2010 - Wiley Online Library
Our aim was to determine the antimicrobial activity of three selected plants (Rosmarinus
officinalis, Origanum majorana, and Trigonella foenum-graecum) against Extended …